date,title,source
Oct-24-18,"Market Trends Toward New Normal in UROGEN PHARMA, Cimarex Energy, Boingo Wireless, TransCanada, EXTRACTION O&G, and ACADIA Pharmaceuticals  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-30-18,FDA Grants Breakthrough Therapy Designation (BTD) for UroGen Pharmas UGN-101 for the Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer (LG UTUC),Business Wire
Nov-05-18,"UroGen Pharma to Report Third Quarter 2018 Financial Results on Monday, November 12, 2018",Business Wire
Nov-06-18,UroGen Pharma to Present at November 2018 Investor Conferences,Business Wire
Nov-12-18,UroGen Pharma Reports Third Quarter 2018 Financial Results and Completed UGN-101 OLYMPUS Trial Enrollment,Business Wire
Dec-03-18,"Market Trends Toward New Normal in Zillow Group, YRC Worldwide, The Home Depot, UROGEN PHARMA, ZIOPHARM Oncology, and Cinedigm  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-17-18,UroGen Pharma Initiates Rolling Submission of New Drug Application (NDA) for UGN-101 for the Treatment of Low-Grade Upper Tract Urothelial Cancer (LG UTUC),Business Wire
Dec-20-18,How Many Insiders Sold UroGen Pharma Ltd. (NASDAQ:URGN) Shares?,Simply Wall St.
